Trisomy 7 in nonneoplastic cells - PubMed (original) (raw)
Review
Trisomy 7 in nonneoplastic cells
B Johansson et al. Genes Chromosomes Cancer. 1993 Apr.
Abstract
The somatic mutation theory of tumorigenesis states that mutations are necessary for tumor development. On the other hand, acquired, clonal chromosomal alterations are occasionally detected in otherwise normal, nonneoplastic cells--for example, loss of sex chromosomes occurs in bone marrow cells and lymphocytes in elderly individuals--and it is therefore evident that not all mutations are by themselves sufficient for neoplasia to occur. Thus, the finding of an acquired, clonal chromosomal abnormality does not constitute proof that a lesion is neoplastic. Trisomy 7 has, as the sole clonal chromosomal aberrations, been reported in a wide variety of epithelial tumor types but also in some mesenchymal and neurogenic neoplasms. It has been suggested to be a primary, i.e., tumor-initiating, abnormality in tumors of the bladder, brain, colon, kidney, lung, ovary, prostate, and thyroid. But data from cytogenetic studies of solid tumors, macroscopically normal tissue in the proximity of solid tumors, and nonneoplastic lesions now question the importance of a solitary +7 as a neoplasia-associated change. Most solid tumors in which trisomy 7 has been found as the sole change in one clone have also displayed other, cytogenetically unrelated, clones with complex karyotypic abnormalities. Such karyotypic differences among coexisting clones could indicate that the neoplasm is polyclonal, that the cytogenetically disparate clones have emerged during tumor progression from one original clone carrying submicroscopic genomic changes only, or that the clone with +7 does not represent the tumor parenchyma. The latter interpretation is supported by the finding of cells with trisomy 7 in macroscopically normal tissue outside tumors of the brain, kidney, and lung.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Trisomy 7 in short-term cultures of colorectal adenocarcinomas.
Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Andrén-Sandberg A, Hägerstrand I, Mitelman F. Bardi G, et al. Genes Chromosomes Cancer. 1991 Mar;3(2):149-52. doi: 10.1002/gcc.2870030211. Genes Chromosomes Cancer. 1991. PMID: 2069912 - Trisomy 7 and sex chromosome loss need not be representative of tumor parenchyma cells in malignant glioma.
Lindström E, Salford LG, Heim S, Mandahl N, Strömblad S, Brun A, Mitelman F. Lindström E, et al. Genes Chromosomes Cancer. 1991 Nov;3(6):474-9. doi: 10.1002/gcc.2870030610. Genes Chromosomes Cancer. 1991. PMID: 1663782 - Cytogenetic analysis of tumor clonality.
Teixeira MR, Heim S. Teixeira MR, et al. Adv Cancer Res. 2011;112:127-49. doi: 10.1016/B978-0-12-387688-1.00005-3. Adv Cancer Res. 2011. PMID: 21925303 Review. - Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors.
Pejovic T, Heim S, Mandahl N, Elmfors B, Flodérus UM, Furgyik S, Helm G, Willén H, Mitelman F. Pejovic T, et al. Genes Chromosomes Cancer. 1990 May;2(1):48-52. doi: 10.1002/gcc.2870020109. Genes Chromosomes Cancer. 1990. PMID: 2177641 - Cytogenetic analysis in the examination of solid tumors in children.
Mertens F, Mandahl N, Mitelman F, Heim S. Mertens F, et al. Pediatr Hematol Oncol. 1994 Jul-Aug;11(4):361-77. doi: 10.3109/08880019409140536. Pediatr Hematol Oncol. 1994. PMID: 7947009 Review.
Cited by
- Genetic characterization of intramuscular myxomas.
Hatchett WJ, Brunetti M, Andersen K, Tandsæther MR, Lobmaier I, Lund-Iversen M, Lien-Dahl T, Micci F, Panagopoulos I. Hatchett WJ, et al. Pathol Oncol Res. 2024 Jan 22;30:1611553. doi: 10.3389/pore.2024.1611553. eCollection 2024. Pathol Oncol Res. 2024. PMID: 38317844 Free PMC article. - Presence of a t(12;18)(q14;q21) Chromosome Translocation and Fusion of the Genes for High-mobility Group AT-Hook 2 (HMGA2) and WNT Inhibitory Factor 1 (WIF1) in Infrapatellar Fat Pad Cells from a Patient With Hoffa's Disease.
Panagopoulos I, Andersen K, Gorunova L, Eilert-Olsen M, Lund-Iversen M, Wessel-Aas T, Lloret I, Micci F, Heim S. Panagopoulos I, et al. Cancer Genomics Proteomics. 2022 Sep-Oct;19(5):584-590. doi: 10.21873/cgp.20343. Cancer Genomics Proteomics. 2022. PMID: 35985683 Free PMC article. - Safety of using cultured cells with trisomy 7 in cell therapy for treating osteoarthritis.
Mizuno M, Ozeki N, Sekiya I. Mizuno M, et al. Regen Ther. 2022 Jun 17;21:81-86. doi: 10.1016/j.reth.2022.06.003. eCollection 2022 Dec. Regen Ther. 2022. PMID: 35785042 Free PMC article. Review. - Karyotyping and analysis of GNAS locus in intramuscular myxomas.
Panagopoulos I, Gorunova L, Lobmaier I, Bjerkehagen B, Heim S. Panagopoulos I, et al. Oncotarget. 2017 Mar 28;8(13):22086-22094. doi: 10.18632/oncotarget.14986. Oncotarget. 2017. PMID: 28160572 Free PMC article. - Mosaicism in health and disease - clones picking up speed.
Forsberg LA, Gisselsson D, Dumanski JP. Forsberg LA, et al. Nat Rev Genet. 2017 Feb;18(2):128-142. doi: 10.1038/nrg.2016.145. Epub 2016 Dec 12. Nat Rev Genet. 2017. PMID: 27941868 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources